How to Add Drug and Regulatory Intelligence to Your Research Workflow — Live Demo

Moving from a trial to the drug behind it and its regulatory history, means switching tools. Until now.

Amass started with two cores: BioMedCore for peer-reviewed literature and TrialCore for clinical trials. Now we're adding two more: DrugCore and RegulatoryCore. The same cross-linked, quality-filtered retrieval now reaches from a target to its drugs and their regulatory footprint.

Jörn and Alex will give the first public look at both new cores, show how all four link together, and demo how to reach them wherever you work: in the app, through the MCP, and over the REST API.

What we will cover

• DrugCore, first look: DrugCore, first look: drug profiles, cross-linked to the papers and trials behind them
• RegulatoryCore, first look: approvals, labels, and milestones as decision support
• One query, four cores: move from literature → trials → drug → regulatory status in a single thread
• Integrations everywhere: app, MCP (Claude, ChatGPT, agents), and REST API. Connect once, use everywhere
• Live demos throughout + Q&A

Who this is for

Researchers, developers, and BD/competitive-intelligence teams who work across literature and trials and now want drug- and regulatory-level evidence in the same connected layer.

---

You can try the Amass API key for free.

When you create an account, you will get $5 of Amass API credits for free.

Sign up for the API here (if you already have a subscription to Amass, then you just need to sign in): https://platform.amass.tech/